Table 2.
1-wk MCT | 2-wk MCT | P value | |
Eradication rate | |||
Intention-to-treat | 34 (56.7) | 29 (76.3) | 0.048 |
Per-protocol | 34 (59.6) | 29 (80.6) | 0.036 |
Compliance | 57 (95.0) | 36 (94.9) | 0.954 |
Side effects | 12 (21.1) | 5 (13.9) | 0.384 |
Nausea | 5 (11.6) | 0 | 0.178 |
Dyspepsia | 4 (7.0) | 1 (2.8) | |
Epigastric soreness | 2 (3.5) | 1 (2.8) | |
Diarrhea | 1 (1.8) | 3 (8.3) |
MCT: Moxifloxacin-containing triple therapy.